Position in LQDA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,102,142
+$3,760,478 QoQ
Shares Held
161,689
+138.1% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$279,369
PutShares
8,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $163,878,430 across 40 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
487,953 | $64,282,928 | |
| 2 | VTRS |
Viatris Inc
|
2,273,599 | $30,716,322 | |
| 3 | ALKS |
Alkermes plc.
|
277,619 | $9,816,607 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
158,093 | $7,612,177 | |
| 5 | LQDA |
Liquidia Corp
This page
|
161,689 | $6,102,142 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
167,580 | $5,047,509 | |
| 7 | PRGO |
PERRIGO Co plc
|
464,742 | $4,991,329 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
63,538 | $4,886,072 |
All Filings in LQDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,102,142 | 161,689 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $279,369 | 8,100 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $2,341,664 | 67,894 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $359,919 | 28,886 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $1,508,335 | 102,260 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $964,320 | 82,000 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,154,702 | 98,189 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,071,560 | 107,156 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $987,264 | 82,272 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $791,101 | 53,634 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $253,484 | 21,071 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $370,606 | 47,211 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $124,684 | 22,920 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $128,746 | 29,529 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $423,943 | 59,045 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $168,754 | 62,734 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $177,971 | 36,173 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $141,194 | 16,769 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $58,229 | 12,363 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||